"Sowaka Health exists to reimagine the way the world accesses life-saving medicines"
To ethically transform global access to complex medicines by connecting underserved patients to trusted therapies through regulatory-first distribution and genuine doctor-patient engagements.
A world where life-saving treatments cross borders with integrity—delivered through Sowaka Health's global backbone of ethical access, healthcare practitioners reach, and transparent policies to navigate regulatory barriers.
"Sowaka Health exists to reimagine the way the world accesses life-saving medicines — especially in fragmented, under-regulated markets like India — by leveraging U.S. regulatory systems to empower underserved populations."
Co-Founder & CBO · USA
Pharmacist | Oncology Strategist | Global Market Leader
Led oncology portfolios for top MNCs in India. Now shaping clinical trial supply solutions across North America.
Co-Founder & CEO · Canada
Global Pharma Leader | 25+ Years of Impact | VP-Level Expertise
Trailblazer in global sourcing, procurement, and business development of finished formulations. Driven by innovation, collaboration, and execution at scale.
The Sowaka Health India Advisory Committee brings together senior leaders from across the Indian pharmaceutical, regulatory, and healthcare supply chain landscape — advising on CDSCO regulatory navigation, supply chain excellence, medical affairs, and India market access.
30+ years leading healthcare supply chains across Bausch & Lomb, Alcon, Novartis, Medikabazaar, and Tata 1mg — advising Sowaka on supply chain architecture, cold-chain logistics, and import-export compliance across India and APAC.
Former Director Regulatory Affairs & Patient Safety at AstraZeneca India, with senior RA leadership at Takeda and Pfizer — advising Sowaka on CDSCO import licensing, Rule 32 compliance, and NPP regulatory strategy.
Physician and senior pharma leader with 25+ years across Eli Lilly, Novartis, BMS, and Sanofi — advising Sowaka on medical affairs, early access program design, and real-world evidence strategy across oncology and rare disease.
35+ years in pharmaceutical Quality Assurance across Novartis, Piramal Healthcare, and Abbott — advising Sowaka on GMP compliance, external supplier qualification, and quality systems for unlicensed medicine import and supply chain operations.